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Abstract We report a 38-year-old patient who presented
with pulmonary hypertension and right ventricular
dysfunction due to pulmonary artery stenoses as a mani-
festation of Williams syndrome, mimicking chronic
thromboembolic pulmonary hypertension. The patient was
treated with balloon angioplasty and stent implantation.
Short-term follow-up showed a good clinical result with
excellent patency of the stents but early restenosis of the
segments in which only balloon angioplasty was per-
formed. These stenoses were subsequently also treated
successfully by stent implantation. Stent patency was ob-
served 3 years after the ﬁrst procedure.
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Pulmonary artery stenosis presenting in adults is
rare. Chronic thromboembolic pulmonary hypertension
(CTEPH) is by far the most common cause of pulmonary
artery stenosis, with an incidence of 0.1–3.8% following a
history of (acute) pulmonary embolism [1, 2]. Stenoses in
these patients are not caused by an abnormality of the
arterial wall itself, but by intraluminal narrowing as a result
of the only partially resolved and organized thromboem-
boli. CTEPH characteristically shows web-like stenoses
and/or ﬁlling defects, which can be present in smaller as
well as larger pulmonary arteries. Nevertheless, distinct
disorders such as large vessel vasculitis, peripheral pul-
monary stenosis (PPS), pulmonary artery compression, and
pulmonary intima sarcoma [3, 4], may mimic the pulmo-
nary vascular occlusions observed in CTEPH.
In general, however, other clinical features will help
with the differential diagnosis. Takayasu arteritis (TA)
typically presents with aortic coarctation [3]. In most pa-
tients with giant cell arteritis [5] and Behc ¸et disease [6]
typical clinical features will accompany the pulmonary
artery stenoses. Although PPS is a well-known entity in
pediatric patients, it is extremely rare in adults [4]. PPS due
to an elastin arteriopathy can be associated with a variety
of congenital syndromes such as congenital rubella, Wil-
liams, Noonan, Alagille, Silver and Ehlers-Danlos [7].
Incidentally, pulmonary artery compression caused by ﬁ-
brosing mediastinitis [8], pulmonary artery sarcoma [9]o r
sarcoidosis [10] may also angiographically mimic CTEPH.
Here, we report Williams syndrome as an unusual cause
of pulmonary artery stenoses in a middle-aged woman.
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In 2003, a 38-year-old woman was referred for analysis of
suspected CTEPH. She was mildly mentally retarded,
which was said to be the consequence of a congenital ru-
bella infection. Two years before admission to our hospital,
she presented with acute dyspnea. Based on a high-prob-
ability ventilation-perfusion scintigraphy, bilateral multiple
pulmonary emboli were diagnosed. Anticoagulant treat-
ment was instituted, whereupon she recovered promptly
and, after discharge, she continued working in a sheltered
workshop without any physical complaint.
She presented with gradually progressive dyspnea on
exertion and a 17 kg weight gain over the preceding few
weeks with signs of right ventricular failure. Systemic
blood pressure was 130/60 mmHg. Selective pulmonary
angiography demonstrated segmental stenoses in both
lungs (Fig. 1A, B), Pulmonary artery pressure (PAP) was
114/36 (mean 64) mmHg, mean right atrial pressure
15 mmHg, pulmonary capillary wedge pressure 15 mmHg,
cardiac output 3.6 l/min, and the pulmonary vascular
resistance 1089 dynes sec cm
–5.
Computed tomography (CT) angiography demonstrated
a dilated pulmonary trunk and main stem arteries and dif-
fusely narrowed and hypoplastic pulmonary segments
(Fig. 2A). A coarctation was demonstrated at the level of
the descending and abdominal aorta with a minimal
diameter of 8 mm. No other vascular abnormalities were
observed. Blood pressure was equal in the two arms and,
because of the absence of hemodynamically signiﬁcant
gradient, the coarctation was left untreated.
In view of the clinical history, CTEPH was considered
to be the most likely cause of the pulmonary hypertension.
Large vessel vasculitis was considered unlikely. Therefore,
a pulmonary endarterectomy (PEA) was offered to the
patient. During surgery, instead of chronic thromboembolic
lesions, diffuse stenoses of the pulmonary arteries were
observed, so PEA could not be performed. A biopsy of the
pulmonary artery was obtained. Postoperatively, despite
aggressive inotropic support, the patient showed signs of
progressive right and left ventricular failure. In view of the
absolute necessity to decrease pulmonary vascular resis-
tance, it was decided to perform balloon angioplasty (BA)
and stent implantation in the pulmonary arteries. Selective
angiography of the left and right pulmonary arteries was
performed using a right femoral approach. After placement
of a guiding catheter in the pulmonary trunk, balloon
angioplasty of four stenoses in segmental arteries was
performed, using a 5 mm angioplasty balloon (Cordis
OPTA PRO Balloon catheter, Cordis, Johnson & Johnson,
Miami Lakes, FL, USA). Immediately thereafter, signiﬁ-
cant residual stenoses were seen at control angiography in
two segmental arteries, the right upper lobe, and right
middle lobe. These were subsequently stented with bal-
loon-expandable stents (5 mm/20 mm, Palmaz Genesis,
Cordis, Johnson & Johnson, Miami Lakes, FL, USA). In
the treated segments no other downstream stenoses were
observed. However, one segmental vessel showed a ste-
nosis and an occlusion distal to it. This vessel was left
untreated.
Immediately after the procedure, the mean PAP de-
creased from 61 to 30 mmHg. The clinical course after this
procedure was uncomplicated and the patient recovered
promptly; she was able to be discharged after 2 weeks. At 3
months follow-up, she was doing well, climbed stairs
without complaints, and had resumed work.
The biopsy showed a thickened intima and media of the
pulmonary arterial wall with diffuse sclerosis and ﬁbrosis.
Genetic analysis was performed and ﬂuorescence in situ
hybridization demonstrated a deletion of the long arm of
chromosome 7 (7q11.23), pathognomonic for Williams
syndrome.
Six months after BA and stent implantation, multislice
CT-angiography demonstrated a decrease in the pulmonary
Fig. 1 A Digital subtraction angiogram of the right pulmonary artery
(oblique view) before treatment, demonstrating stenoses at the origin
of the right superior lobe trunk, the middle lobe artery, and the lower
lobe trunk (arrows). B Digital subtraction angiogram of the left
pulmonary artery (oblique view) before treatment, demonstrating
occlusion of the left upper lobe and multiple stenoses in the segmental
branches of the lower lobe artery (arrows)
H. J. Reesink et al.: Pulmonary Arterial Stent Implantation 783
123trunk from 3.5 to 2.9 cm. Both stents were patent (Fig. 2B).
Repeat pulmonary angiography conﬁrmed this observation.
However, the pulmonary arterial segments that were trea-
ted with BA only showed restenosis. In view of the pa-
tient’s good clinical condition, these were left untreated.
However, at 24 months follow-up, she again showed signs
of right ventricular failure. At this time it was decided to
treat the residual stenotic branches of the pulmonary
arteries with stent implantation. A similar technique as
described before was used. Under general anesthesia, a
total of ﬁve stents (5 mm/20 mm, Palmaz Genesis, Cordis,
Johnson & Johnson, Miami Lakes, FL, USA ) were im-
planted in four stenotic segmental lesions (one stent in the
right lower lobe and four stents in three segments of the left
lower lobe). After this procedure, the mean PAP had de-
creased from 40 to 29 mmHg. The patient recovered well
and was discharged 2 days after the procedure. One year
later, i.e., 3 years after the initial procedure, control pul-
monary angiography showed patent stents in all treated
pulmonary segmental branches (Fig. 3A, B). The PAP was
53/18 (mean 32) mmHg. Over the stents in the right and
left lower lobes, a pressure gradient of only 3 mmHg was
measured.
Discussion
In this case report we described a 38-year-old patient who
presented with recent-onset pulmonary hypertension due to
pulmonary artery stenoses as a manifestation of Williams
syndrome mimicking CTEPH. The patient was treated with
BA and stenting. Short-term follow-up showed a good
clinical result with excellent patency of the stents but early
restenosis of the segments in which only BA was per-
formed. All stents were patent after 3 years of follow-up.
In contrast to pediatric patients, in adults with pulmo-
nary artery stenoses BA and stenting are not routinely
performed. BA in 12 adult patients with isolated PPS was
reported by Kreutzer and coworkers [4]. No speciﬁc
diagnoses were reported in these patients [4]. Nine of 12
patients were successfully treated, with a follow-up of 52 ±
32 months. Rothman et al.. described 4 cases of adult PPS
treated by BA [11]. One patient was free of symptoms for
10 years, whereas in 3 of 4 patients restenosis occurred 4–
24 months after BA. They were treated with repeat BA and
stent implantation was performed in 2 of the 4. One patient
developed stent occlusion, 1 patient died 2 years after stent
implantation without other interventions, and 1 patient had
an uneventful follow-up for at least 18 months. Further-
more, successful use of BA and stent implantation in
incidental cases with pulmonary artery stenoses have been
reported [8, 12–15]. BA was also reported to be successful
in inoperable CTEPH patients [16]. In Williams syndrome,
treatment of pulmonary stenoses with BA and stent
implantation has been previously reported in pediatric pa-
tients only [17, 18]. Another technique which has been
reported in children is the use of cutting-balloon angio-
plasty, and this seems to yield favorable results at follow-
up compared with conventional BA [19, 20]. As cutting
balloons have recently become available in larger sizes, up
Fig. 2 A Sagittal-oblique thick
maximum intensity projection
image of the multislice
computed tomography
angiogram (slice thickness 10
mm) before treatment, showing
the stenotic right middle lobe
artery (arrowhead). B Repeat
computed tomography 6 months
after stent placement in the right
middle lobe artery in the same
projection as in A
Fig. 3 A, B Digital subtraction
angiogram of the right A and
left B pulmonary artery (oblique
view) 3 years after the initial
stenting procedure, showing
excellent patency of the stents in
the right upper, middle and
lower lobe arteries and in the
left lower lobe arteries (arrows)
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123to 8 mm, this technique may become an option for treat-
ment of stenoses in adult-sized arteries.
At 6 months follow-up, we observed restenosis of the
BA-treated vessels, whereas all vessels with stent implan-
tation were still patent. This seems consistent with earlier
observations in pediatric patients [17, 18]. Relapses after
BA therefore appear to be relatively frequent in patients
with Williams syndrome. A likely explanation for this is
the consistency of the pulmonary artery in these cases.
Williams syndrome is a congenital developmental disorder
involving the vascular, connective tissue, and central ner-
vous systems that affects 1:20,000 newborns [21]. Deletion
of the long arm of chromosome 7 (7q11.23), which en-
codes for the elastin gene, results in decreased elastin
production, affecting the heart, face, and bones. As a
consequence, as in our patient, the arterial wall is dif-
fusely thickened, consisting of intimal proliferation and
medial dysplasia with hypertrophy, ﬁbrosis, and a mosaic
arrangement of smooth muscle cells [17, 18]. This might
explain why in these patients stent implantation is superior
to BA. Stent patency was observed 3 years after the ﬁrst
procedure. Moreover, the stents did not contribute to the
residual pulmonary hypertension observed. However, im-
paired vascular elastin production without clinical signs of
Williams syndrome may affect some (pediatric) patients.
This autosomal dominant disorder might be caused by
mutations or microdeletions in the elastin gene that are not
detected by ﬂuorescence in situ hybridization [22].
In conclusion, we performed a rescue BA and successful
multiplestent implantationinapatientwhowaserroneously
diagnosed with CTEPH. Stenting was shown to be superior
to BA alone in this patient with Williams syndrome.
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